HALO vs WTW · P/E 15, rev $857.7M vs P/E 15, rev $4.88B
Halozyme Therapeutics Inc (HALO) versus Willis Towers Watson PLC (WTW) — a side-by-side from cached financials, not a winner call.
Halozyme Therapeutics Inc (HALO) is a biotechnology company listed on US.
Willis Towers Watson PLC (WTW) is a insurance brokers company listed on NASDAQ.
Latest reported HALO revenue for 2026-06-30 was $857.7M. Net income was $380.0M. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
Latest reported WTW revenue for 2026-06-30 was $4.88B. Net income was $526.0M. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
HALO currently screens at market cap $7.10B and trailing P/E 15.3. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
Not investment advice. Open the HALO and WTW stock pages for the full models.
Not investment advice.